Yuanli Chemical Group Co.,Ltd. (SHA:603217)
China · Delayed Price · Currency is CNY 25.28
+0.10 (0.40%)
At close: Feb 13, 2026
Yuanli Chemical Group Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Revenue | 2,114 | 2,178 | 2,149 | 2,664 | 2,334 | 1,221 |
Other Revenue | 41.96 | 41.96 | 31.91 | 19.26 | 9.68 | 0.96 |
| 2,156 | 2,220 | 2,181 | 2,683 | 2,343 | 1,222 | |
Revenue Growth (YoY) | -2.69% | 1.75% | -18.70% | 14.49% | 91.77% | 4.69% |
Cost of Revenue | 1,775 | 1,846 | 1,785 | 1,983 | 1,788 | 961.81 |
Gross Profit | 380.96 | 373.29 | 396.25 | 700.08 | 555.26 | 260.22 |
Selling, General & Admin | 92.1 | 87.46 | 82.96 | 98.15 | 58.4 | 44.22 |
Research & Development | 88.39 | 94.15 | 91.24 | 115.3 | 87.98 | 54.4 |
Other Operating Expenses | 3.85 | -2.9 | -1.11 | 11.54 | 10.28 | 6.57 |
Operating Expenses | 183.52 | 179.45 | 172.2 | 225.15 | 159.19 | 105.98 |
Operating Income | 197.44 | 193.84 | 224.05 | 474.94 | 396.08 | 154.24 |
Interest Expense | -2.1 | -2.1 | -0.03 | -0.01 | -0.02 | - |
Interest & Investment Income | 41.88 | 43.04 | 48.21 | 46.56 | 36.83 | 35.96 |
Currency Exchange Gain (Loss) | 5.52 | 5.52 | 4.2 | 9.86 | -7.48 | -3.25 |
Other Non Operating Income (Expenses) | -5.56 | -1.37 | -1.72 | -0.33 | -0.86 | -0.53 |
EBT Excluding Unusual Items | 237.18 | 238.93 | 274.71 | 531.02 | 424.53 | 186.42 |
Gain (Loss) on Sale of Investments | 0.96 | - | 6.42 | 3.34 | 1.99 | - |
Gain (Loss) on Sale of Assets | 1.16 | 0.03 | 0.01 | -2.54 | -6.13 | -8.75 |
Asset Writedown | 0.25 | - | -0.01 | - | -8.7 | - |
Other Unusual Items | 0.32 | 0.86 | 19.6 | 4.52 | 9.52 | 7.71 |
Pretax Income | 239.87 | 239.82 | 300.73 | 536.59 | 421.37 | 185.4 |
Income Tax Expense | 37.27 | 32.69 | 51.05 | 67.26 | 61.26 | 27.61 |
Net Income | 202.6 | 207.13 | 249.68 | 469.33 | 360.11 | 157.79 |
Net Income to Common | 202.6 | 207.13 | 249.68 | 469.33 | 360.11 | 157.79 |
Net Income Growth | -9.13% | -17.04% | -46.80% | 30.33% | 128.22% | 15.78% |
Shares Outstanding (Basic) | 206 | 205 | 206 | 164 | 203 | 204 |
Shares Outstanding (Diluted) | 206 | 205 | 206 | 164 | 203 | 204 |
Shares Change (YoY) | 0.74% | -0.61% | 25.74% | -19.34% | -0.07% | 13.91% |
EPS (Basic) | 0.98 | 1.01 | 1.21 | 2.86 | 1.77 | 0.78 |
EPS (Diluted) | 0.98 | 1.01 | 1.21 | 2.86 | 1.77 | 0.78 |
EPS Growth | -9.79% | -16.53% | -57.69% | 61.58% | 128.39% | 1.64% |
Free Cash Flow | 161.53 | -51.38 | -45.15 | 376.46 | 39.06 | 110.03 |
Free Cash Flow Per Share | 0.78 | -0.25 | -0.22 | 2.29 | 0.19 | 0.54 |
Dividend Per Share | 0.350 | 0.350 | 0.400 | 0.500 | 0.500 | 0.237 |
Dividend Growth | -12.50% | -12.50% | -20.00% | - | 110.53% | -11.35% |
Gross Margin | 17.67% | 16.82% | 18.17% | 26.09% | 23.69% | 21.29% |
Operating Margin | 9.16% | 8.73% | 10.27% | 17.70% | 16.90% | 12.62% |
Profit Margin | 9.40% | 9.33% | 11.45% | 17.49% | 15.37% | 12.91% |
Free Cash Flow Margin | 7.49% | -2.31% | -2.07% | 14.03% | 1.67% | 9.00% |
EBITDA | 297.39 | 291.98 | 319.79 | 556.81 | 484.31 | 234.81 |
EBITDA Margin | 13.79% | 13.15% | 14.66% | 20.75% | 20.67% | 19.21% |
D&A For EBITDA | 99.95 | 98.14 | 95.74 | 81.88 | 88.24 | 80.57 |
EBIT | 197.44 | 193.84 | 224.05 | 474.94 | 396.08 | 154.24 |
EBIT Margin | 9.16% | 8.73% | 10.27% | 17.70% | 16.90% | 12.62% |
Effective Tax Rate | 15.54% | 13.63% | 16.97% | 12.53% | 14.54% | 14.89% |
Revenue as Reported | 2,156 | 2,220 | 2,181 | 2,683 | 2,343 | 1,222 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.